Báo cáo y học: " Development of a new ultra sensitive real-time PCR assay (ultra sensitive RTQ-PCR) for the quantification of HBV-DNA"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Development of a new ultra sensitive real-time PCR assay (ultra sensitive RTQ-PCR) for the quantification of HBV-DNA | Paraskevis et al. Virology Journal 2010 7 57 http content 7 1 57 VIROLOGY JOURNAL METHODOLOGY Open Access Development of a new ultra sensitive real-time PCR assay ultra sensitive RTQ-PCR for the quantification of HBV-DNA Dimitrios Paraskevis1 Apostolos Beloukas1 Catherine Haida1 Antigoni Katsoulidou1 Zisis Moschidis1 Helen Hatzitheodorou1 Agoritsa Varaklioti2 Vana Sypsa1 Angelos Hatzakis1 Abstract Background Improved sensitivity of HBV-DNA tests is of critical importance for the management of HBV infection. Our aim was to develop and assess a new ultra sensitive in-house real-time PCR assay for HBV-DNA quantification ultra sensitive RTQ-PCR . Results Previously used HBV-DNA standards were calibrated against the WHO 1st International Standard for HBV-DNA OptiQuant HBV-DNA Quantification Panel Accrometrix Europe . . The 95 and 50 HBV-DNA detection end-point of the assay were and IU mL. According to the calibration results 1 IU mL equals copies mL. Importantly the clinical performance of the ultra sensitive real-time PCR was tested similar 67 to the Procleix Ultrio discriminatory HBV test dHBV 70 in low-titer samples from patients with occult Hepatitis B. Finally in the comparison of ultra sensitive RTQ-PCR with the commercially available COBAS TaqMan HBV Test the in-house assay identified of the 94 specimens as positive versus identified by TaqMan while the quantitative results that were positive by both assay were strongly correlated r . Conclusions We report a new ultra sensitive real time PCR molecular beacon based assay with remarkable analytical and clinical sensitivity calibrated against the WHO 1st International standard. Background Chronic hepatitis B virus HBV infection can be assessed by evaluating clinical features and biochemical virologic and histologic parameters. Knowledge of HBV-DNA viral load is useful for predicting disease prognosis determining infectivity evaluating indications for treatment .

Không thể tạo bản xem trước, hãy bấm tải xuống
TÀI LIỆU LIÊN QUAN
TÀI LIỆU MỚI ĐĂNG
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.